PHILADELPHIA, PA, UNITED STATES - May 11, 2015 - ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announcedan expansion to its Executive Management team. Andrea Valente has been named Executive Vice President and Chief Development Officer.

Andrea comes to ERT with over 20 years of professional services, product development and sales leadership experience, including her most recent role as Chief Operating Officer of PHT Corporation. ERT acquired PHT in May 2015.

“I’m pleased to draw upon the talent within PHT to build an innovative, customer-focused and growth-driven company,” said Jim Corrigan, President and CEO of ERT. “With the addition of Andrea to our Executive Management team, I’m confident we have the right people in place to position ERT for great success over the long term.”

In her new role, Andrea will lead development, information technology and strategic sourcing for ERT globally while also serving as a key member of the executive leadership team that provides strategic direction for the entire organization. 

“I’m very excited to add my experience to ERT’s knowledgeable leadership team during this exciting time in the company’s growth,” said Valente. “I’m eager to jump right in to ensure our customers have the products and services that will enable them to capture the highest quality safety and efficacy endpoint data possible.”

For more information on ERT’s leadership team, visitwww.ert.com/about-us/ert-leadership.

About ERT

ERT (www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development.  ERT delivers a combination of technology, services and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle.  ERT delivers the most widely deployed solutions in centralized cardiac safety, respiratory services, suicide risk assessment and Clinical Outcome Assessments (COAs) - which includes patient, clinician and observer reported outcomes.  By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products.  ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Japan and Germany.